CLMB
Climb Global Solutions, Inc.
CLMB's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CLMB overall, supported by stronger valuation and stronger modeled upside.
CLMB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
CLMB's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CLMB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $18.74 | -57% |
| Fair | 20x | $26.20 | -39% |
| Forward | 21x | $43.09 | — |
| Expensive | 26x | $33.59 | -22% |
| Current | 33x | $43.09 | — |
Historical ranges are pointers, not guarantees.
CLMB's PE is in its expensive range at 33x. If earnings grow as analysts expect, today's price would be 21x next year's earnings, in its fair range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over CLMB in the historical PE scenario, which offers more potential upside but is not a forecast.
CLMB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
CLMB has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CLMB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.06 | +60% |
| Q3 2026 | $1.29 | +11% |
| Q2 2026 | $1.11 | -7.5% |
| Q1 2026 | $1.14 | +6.5% |
| Q4 2025 | $1.16 | +15% |
| Q3 2025 | $1.16 | +26% |
| Q2 2025 | $1.20 | +58% |
| Q1 2025 | $1.07 | +65% |
| Q4 2024 | $1.01 | +49% |
CLMB earned $1.29 per share over the past year, up 11% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CLMB on earnings, with more consistent year-over-year improvement.
CLMB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $220.3M | +37% |
| Q2 2026 | $174.2M | +9.4% |
| Q1 2026 | $182.4M | +32% |
| Q4 2025 | $193.8M | +20% |
| Q3 2025 | $161.3M | +35% |
| Q2 2025 | $159.3M | +73% |
| Q1 2025 | $138M | +49% |
| Q4 2024 | $161.8M | +51% |
CLMB's revenue has grown year over year for 17 quarters in a row: $220M last quarter, up 37% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.5% | +0.2 points |
| Q2 2026 | 4.2% | -0.8 points |
| Q1 2026 | 2.1% | -1.3 points |
| Q4 2025 | 4.9% | -2.3 points |
| Q3 2025 | 4.3% | -2.8 points |
| Q2 2025 | 5% | +0.4 points |
| Q1 2025 | 3.5% | -0.3 points |
| Q4 2024 | 7.3% | +0.3 points |
CLMB's operating margin was 4.5% last quarter, about level with the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CLMB on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CLMB on profitability, with a higher operating margin.
CLMB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.1M | -50% |
| Q2 2026 | $14.9M | +$17.1M |
| Q1 2026 | $16.3M | +93% |
| Q4 2025 | -$11.9M | -174% |
| Q3 2025 | $22.2M | +$25.8M |
| Q2 2025 | -$2.2M | -130% |
| Q1 2025 | $8.5M | -40% |
| Q4 2024 | $16M | +324% |
CLMB still generates free cash flow, though less than at its 2023 peak: $30M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CLMB on cash flow, with more consistent year-over-year improvement.
CLMB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +27K shares |
| 1 year | +1% | +179K shares |
| 3 years | +3.8% | +667K shares |
| 5 years | +7% | +1.2M shares |
| Available history | +3.6% | +639K shares |
CLMB has 18M diluted shares, up 1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $182,000 |
| Q2 2026 | $146,000 |
| Q1 2026 | $1.5M |
| Q4 2025 | $320,000 |
| Q3 2025 | $307,000 |
| Q2 2025 | $540,000 |
| Q1 2025 | $883,000 |
| Q4 2024 | $555,000 |
CLMB spent $2M buying back its own shares over the past year, down 6.3% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CLMB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CLMB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.7x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
CLMB has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CLMB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.6 | Overbought |
| Stochastic | 84.0 | Overbought |
CLMB's weekly RSI is 79 (overbought) and its Stochastic is 84 (overbought).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CLMB PE vs Technology Sector
| Metric | CLMB | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 28x | 20% above |
| PE % | 95 | 35 | 60 pts above |
CLMB is trading at 33x earnings, a 20% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over CLMB on valuation relative to its sector.
CLMB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.7 | 21% above |
| 20 week MA | $30.6 | 41% above |
| 50 week MA | $26.8 | 61% above |
| 100 week MA | $28.0 | 54% above |
| 200 week MA | $21.8 | 98% above |
CLMB has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CLMB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.01 | $4.85 | +21% |
| 2021 | $4.85 | $8.92 | +84% |
| 2022 | $8.92 | $7.82 | -12% |
| 2023 | $7.82 | $13.7 | +75% |
| 2024 | $13.7 | $31.6 | +130% |
| 2025 | $31.6 | $26.0 | -18% |
| 2026 YTD | $26.0 | $43.1 | +66% |
CLMB has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.